Pioglitazone Attenuates Drug-Eluting Stent-Induced Proinflammatory State in Patients by Blocking Ubiquitination of PPAR
The inflammatory response after polymer-based drug-eluting stent (DES) placement has recently emerged as a major concern. The biologic roles of peroxisome proliferator-activated receptor-γ (PPAR-γ) activators thiazolidinedione (TZD) remain controversial in cardiovascular disease. Herein, we investig...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | PPAR Research |
| Online Access: | http://dx.doi.org/10.1155/2016/7407153 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832567154424152064 |
|---|---|
| author | Zhongxia Wang Tao Zhang Lizhe Sun Ruifeng Li Yuanyuan Wei Xiaojuan Fan Zuyi Yuan Junhui Liu Tao Chen |
| author_facet | Zhongxia Wang Tao Zhang Lizhe Sun Ruifeng Li Yuanyuan Wei Xiaojuan Fan Zuyi Yuan Junhui Liu Tao Chen |
| author_sort | Zhongxia Wang |
| collection | DOAJ |
| description | The inflammatory response after polymer-based drug-eluting stent (DES) placement has recently emerged as a major concern. The biologic roles of peroxisome proliferator-activated receptor-γ (PPAR-γ) activators thiazolidinedione (TZD) remain controversial in cardiovascular disease. Herein, we investigated the antiinflammatory effects of pioglitazone (PIO) on circulating peripheral blood mononuclear cells (MNCs) in patients after coronary DES implantation. Methods and Results. Twenty-eight patients with coronary artery disease and who underwent DES implantations were randomly assigned to pioglitazone (30 mg/d; PIO) or placebo (control; Con) treatment in addition to optimal standard therapy. After 12 weeks of treatment, plasma concentrations of high-sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and matrix metalloproteinase-9 (MMP-9) were significantly decreased in PIO group compared to the Con group (P=0.035, 0.011, 0.008, and 0.012, resp.). DES-induced mRNA expressions of IL-6, TNF-α, and MMP-9 in circulating MNC were significantly blocked by PIO (P=0.031, 0.012, and 0.007, resp.). In addition, PIO markedly inhibited DES-enhanced NF-κB function and DES-blocked PPAR-γ activity. Mechanically, DES induced PPAR-γ ubiquitination and degradation in protein level, which can be totally reversed by PIO. Conclusion. PIO treatment attenuated DES-induced PPAR loss, NF-κB activation, and proinflammation, indicating that PIO may have a novel direct protective role in modulating proinflammation in DES era. |
| format | Article |
| id | doaj-art-206db5b901f847349dc92b0ffeddf426 |
| institution | Kabale University |
| issn | 1687-4757 1687-4765 |
| language | English |
| publishDate | 2016-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | PPAR Research |
| spelling | doaj-art-206db5b901f847349dc92b0ffeddf4262025-02-03T01:02:06ZengWileyPPAR Research1687-47571687-47652016-01-01201610.1155/2016/74071537407153Pioglitazone Attenuates Drug-Eluting Stent-Induced Proinflammatory State in Patients by Blocking Ubiquitination of PPARZhongxia Wang0Tao Zhang1Lizhe Sun2Ruifeng Li3Yuanyuan Wei4Xiaojuan Fan5Zuyi Yuan6Junhui Liu7Tao Chen8Department of Cardiology, First Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710061, ChinaDepartment of Cardiology, First Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710061, ChinaDepartment of Cardiology, First Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710061, ChinaDepartment of Cardiology, First Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710061, ChinaDepartment of Cardiology, First Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710061, ChinaDepartment of Cardiology, First Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710061, ChinaDepartment of Cardiology, First Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710061, ChinaDepartment of Cardiology, First Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710061, ChinaDepartment of Cardiology, First Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710061, ChinaThe inflammatory response after polymer-based drug-eluting stent (DES) placement has recently emerged as a major concern. The biologic roles of peroxisome proliferator-activated receptor-γ (PPAR-γ) activators thiazolidinedione (TZD) remain controversial in cardiovascular disease. Herein, we investigated the antiinflammatory effects of pioglitazone (PIO) on circulating peripheral blood mononuclear cells (MNCs) in patients after coronary DES implantation. Methods and Results. Twenty-eight patients with coronary artery disease and who underwent DES implantations were randomly assigned to pioglitazone (30 mg/d; PIO) or placebo (control; Con) treatment in addition to optimal standard therapy. After 12 weeks of treatment, plasma concentrations of high-sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and matrix metalloproteinase-9 (MMP-9) were significantly decreased in PIO group compared to the Con group (P=0.035, 0.011, 0.008, and 0.012, resp.). DES-induced mRNA expressions of IL-6, TNF-α, and MMP-9 in circulating MNC were significantly blocked by PIO (P=0.031, 0.012, and 0.007, resp.). In addition, PIO markedly inhibited DES-enhanced NF-κB function and DES-blocked PPAR-γ activity. Mechanically, DES induced PPAR-γ ubiquitination and degradation in protein level, which can be totally reversed by PIO. Conclusion. PIO treatment attenuated DES-induced PPAR loss, NF-κB activation, and proinflammation, indicating that PIO may have a novel direct protective role in modulating proinflammation in DES era.http://dx.doi.org/10.1155/2016/7407153 |
| spellingShingle | Zhongxia Wang Tao Zhang Lizhe Sun Ruifeng Li Yuanyuan Wei Xiaojuan Fan Zuyi Yuan Junhui Liu Tao Chen Pioglitazone Attenuates Drug-Eluting Stent-Induced Proinflammatory State in Patients by Blocking Ubiquitination of PPAR PPAR Research |
| title | Pioglitazone Attenuates Drug-Eluting Stent-Induced Proinflammatory State in Patients by Blocking Ubiquitination of PPAR |
| title_full | Pioglitazone Attenuates Drug-Eluting Stent-Induced Proinflammatory State in Patients by Blocking Ubiquitination of PPAR |
| title_fullStr | Pioglitazone Attenuates Drug-Eluting Stent-Induced Proinflammatory State in Patients by Blocking Ubiquitination of PPAR |
| title_full_unstemmed | Pioglitazone Attenuates Drug-Eluting Stent-Induced Proinflammatory State in Patients by Blocking Ubiquitination of PPAR |
| title_short | Pioglitazone Attenuates Drug-Eluting Stent-Induced Proinflammatory State in Patients by Blocking Ubiquitination of PPAR |
| title_sort | pioglitazone attenuates drug eluting stent induced proinflammatory state in patients by blocking ubiquitination of ppar |
| url | http://dx.doi.org/10.1155/2016/7407153 |
| work_keys_str_mv | AT zhongxiawang pioglitazoneattenuatesdrugelutingstentinducedproinflammatorystateinpatientsbyblockingubiquitinationofppar AT taozhang pioglitazoneattenuatesdrugelutingstentinducedproinflammatorystateinpatientsbyblockingubiquitinationofppar AT lizhesun pioglitazoneattenuatesdrugelutingstentinducedproinflammatorystateinpatientsbyblockingubiquitinationofppar AT ruifengli pioglitazoneattenuatesdrugelutingstentinducedproinflammatorystateinpatientsbyblockingubiquitinationofppar AT yuanyuanwei pioglitazoneattenuatesdrugelutingstentinducedproinflammatorystateinpatientsbyblockingubiquitinationofppar AT xiaojuanfan pioglitazoneattenuatesdrugelutingstentinducedproinflammatorystateinpatientsbyblockingubiquitinationofppar AT zuyiyuan pioglitazoneattenuatesdrugelutingstentinducedproinflammatorystateinpatientsbyblockingubiquitinationofppar AT junhuiliu pioglitazoneattenuatesdrugelutingstentinducedproinflammatorystateinpatientsbyblockingubiquitinationofppar AT taochen pioglitazoneattenuatesdrugelutingstentinducedproinflammatorystateinpatientsbyblockingubiquitinationofppar |